future glp-1 drugs Medications: Everything You Need to Know GLP-1 Drugs: Where We Are

doi: 10.3389/fmed.2024.1442525 Received 02 June 2024 Accepted 30 October 2024 Published 14 November 2024 Volume 11 - 2024 Edited by Thierry Thvenot, University Hospital of Besanon, France Reviewed by Qianqian Zhang, First Affiliated Hospital of Anhui Medical University, China Jonathan Soldera, University of Caxias do Sul, Brazil Juan Pablo Roblero, Clinical Hospital of the University of Chile, Chile Updates Copyright 2024 Philips

Acknowledgements The authors' research work is funded by grants from the National Institute on Aging (RO1 AG044034 to R.F.L

can mimic hematuria Orange Rifampicin, Phenazopyridine, Sulfasalazine, Warfarin Excretion of drug pigments Brown Metronidazole, Levodopa, Nitrofurantoin, Chloroquine, Methyldopa Oxidation of metabolites in urine Black Levodopa, Methyldopa, Phenol poisoning Formation of melanin-like compounds on standing Blue / Green Amitriptyline, Indomethacin, Cimetidine, Propofol, Methylene blue Drug dyes or metabolite excretion Purple Catheter-associated Purple Urine Bag Syndrome (from bacteria metabolizing tryptophan) Seen in catheterized patients with infection Yellow (Intense) Vitamin B-complex (esp

Contains no: Gluten, yeast, corn, artificial colorings, flavors, and preservatives

Pentoxifylline in diabetic kidney disease (VA PTXRx): protocol for a pragmatic randomised controlled trial

MK2 is required for neutrophil-derived ROS production and inflammatory bowel disease